Marine Indole Alkaloids: Potential New Drug Leads for the Control of Depression and Anxiety
Top Cited Papers
- 9 April 2010
- journal article
- review article
- Published by American Chemical Society (ACS) in Chemical Reviews
- Vol. 110 (8), 4489-4497
- https://doi.org/10.1021/cr900211p
Abstract
No abstract availableThis publication has 58 references indexed in Scilit:
- The molecular neurobiology of depressionNature, 2008
- The behavioral pharmacology of hallucinogensBiochemical Pharmacology, 2008
- Indolic metabolites from the new marine bacterium Roseivirga echinicomitans KMM 6058TChemistry of Natural Compounds, 2006
- Indole alkaloid marine natural products: An established source of cancer drug leads with considerable promise for the control of parasitic, neurological and other diseasesLife Sciences, 2005
- 3,6-Dibromoindole, A New Indole From the Palauan Ascidian Distaplia ReginaNatural Product Letters, 1999
- N-Methyl-5-tert-butyltryptamine: A Novel, Highly Potent 5-HT1D Receptor AgonistJournal of Medicinal Chemistry, 1999
- Antioxidative Bromoindole Derivatives from the Mid-Intestinal Gland of the Muricid Gastropod Drupella fragumJournal of Natural Products, 1998
- Alcaloïdes d'une Ascidie Neocaledonienne, Eudistoma fragumJournal of Natural Products, 1988
- Marine indoles of novel substitution pattern from the acorn wormGlossobalanus sp.Cellular and Molecular Life Sciences, 1985
- N-Phenyl-2-indolinones and N-phenylindolines. New class of antidepressant agentsJournal of Medicinal Chemistry, 1972